Introduction: In 2009, the Swedish pharmaceuticals market was reformed. One of the stated policy goals was to achieve … generic pharmaceuticals have been collected, and a log-linear regression model was used to estimate how the policy changes … supplying off-patent pharmaceuticals experienced a clear reduction in the price received for their products. …

name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper, the … introduction of the substitution reform in the Swedish pharmaceuticals market in October 2002 is used as a natural experiment … lowered the price of both brand name- and generic pharmaceuticals. …

price of brand name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper …, the introduction of the substitution reform in the Swedish pharmaceuticals market in October 2002 is used as a natural … reform has lowered the price of both brand name- and generic pharmaceuticals. …

In October 2002 a substitution reform was introduced in the Swedish Pharmaceuticals market. In this note, the effects …

generic pharmaceuticals during the first four years after the reform. The results also show that the price adjustment was not …

Given the cost of trade and availability of pharmaceuticals, the driving force for parallel trade is the price … availability of pharmaceuticals for parallel trade should increase price competition in the destination country. Using 2003 …

Given the cost of trade and availability of pharmaceuticals, the driving force for parallel trade is the price … availability of pharmaceuticals for parallel trade should increase price competition in the destination country. Using 2003 …

Given the cost of trade and availability of pharmaceuticals, the driving force for parallel trade is the price … availability of pharmaceuticals for parallel trade should increase price competition in the destination country. Using 2003 …